VAC shorts ease as an activist trims and Street stays split

Marriott Vacations Worldwide has gained 6.8% on the week and 13.8% over the past month, yet the analyst community remains fractured between buyers with targets well above the current price and bears who think the rally has already overshot.

The most newsworthy structural fact about VAC right now is the presence of an activist on its register. Impactive Capital LP filed a Schedule 13D in May 2025 and has amended it twice since, most recently on 20 August 2026. Its current disclosed stake is 9.8% of the class, down from 11.7% at the prior filing. That August trim coincided with a 750,000-share open-market sale at $111.49, worth roughly $83.6 million, filed by Christian Asmar, who appears as a director and 10% owner on the Form 4. The reduction is material: Impactive has shed roughly two percentage points of class ownership in a single amendment. The 13D designation means Impactive filed with active intent, not as a passive holder, and that distinction matters. As always with 13D/G disclosures, positions are as last filed around the 5% threshold and a holder can exit without further notice once below that level.

Short positioning reads as a secondary story rather than the central one. At 5.6% of free float, the short interest level is worth watching but far from extreme. It has also been drifting lower this week, down about 2.4% over the past five sessions to roughly 1.95 million shares. The borrow market is entirely relaxed: availability runs above 1,000% of shares currently short, meaning lenders hold more than ten times the shares needed to cover every open position, and the cost to borrow is under 0.5%. There is no meaningful squeeze pressure here. Options positioning is similarly calm. The put/call ratio of 0.72 sits only half a standard deviation above its 20-day average of 0.63, well within normal range and far from the 52-week defensive extreme of 1.52. Taken together, the lending and options picture looks neither crowded nor charged.

The analyst debate is where the genuine tension lies. JP Morgan initiated in October with an Overweight and a $125 target, the most recent constructive call. Morgan Stanley, by contrast, maintains Underweight with a target of just $63, a level that would imply the stock is already trading at nearly twice fair value in their framework. Wells Fargo also sits at Underweight, with a $100 target. Barclays and Truist are more optimistic, holding Overweight and Buy respectively with targets of $140 and $134. The consensus mean of $123 sits modestly above the current price of $118.59, but the spread between the highest and lowest targets is unusually wide, reflecting genuine disagreement about whether VAC's margin recovery is durable. The bull case rests on development margins that improved 1,000 basis points year-on-year to 24.7%. The bear case focuses on exchange revenues down 10%, contract sales down 1%, and active membership falling 2% to roughly 1.5 million. The 90-day EPS momentum factor ranks in the 88th percentile, while the analyst recommendation divergence score ranks 93rd, an unusually high reading that formally captures how split the Street is. The PE of 12.5x has expanded by 1.6 turns over the past 30 days, tracking the stock's re-rating.

The ownership picture adds one further wrinkle. BlackRock holds 12.5% and has been adding modestly, while Vanguard's restructuring across its entities left one entity at zero and a separate Vanguard Portfolio Management vehicle filing a fresh 13G in April at 5.6%. The top two holders account for more than 22% of shares between them, giving the register a concentrated feel. Wikipedia attention, the only alt-data signal available, is running nearly two standard deviations below VAC's own 90-day average, suggesting retail interest in the name is subdued despite the rally.

Peer context adds texture to the week's move. Closest correlated name TNL gained 12.2% on the week, and timeshare peer HGV surged 16.9%, suggesting sector tailwinds rather than VAC-specific re-rating drove much of the move. With next earnings not until 24 February 2027, the stock now settles into a long inter-earnings window where the Impactive Capital stake evolution, any further Morgan Stanley or JP Morgan moves, and monthly contract sales data are the primary things worth tracking.